Related Experiment Video
Updated: Jul 4, 2025

Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
Published on: May 27, 2016
Identification of differentially expressed miRNAs in plasma exosomes from patients with early-onset pre-eclampsia
Wuqian Wang1,2, Weihua Zhang2, Luan Chen1
1Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai 200030, China.
Insights
This study identified 65 differentially expressed microRNAs (miRNAs) in the exosomes of early-onset pre-eclampsia (PE) patients. These findings suggest specific miRNAs may serve as biomarkers and play a role in PE pathogenesis.
Area of Science:
- Biochemistry
- Genetics
- Molecular Biology
Background:
- Pre-eclampsia (PE) is a significant cause of maternal and fetal mortality, with unclear pathogenesis.
- Identifying molecular markers for early diagnosis and understanding PE development is crucial.
Purpose of the Study:
- To identify differentially expressed microRNAs (miRNAs) in peripheral blood exosomes of early-onset PE patients.
- To discover candidate miRNAs as potential molecular markers for PE.
Main Methods:
- High-throughput sequencing of exosomal miRNAs from five PE patients and five healthy pregnant women.
- Bioinformatic analysis including target gene prediction, Gene Ontology (GO), and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis.
- Quantitative PCR (qPCR) validation of selected miRNAs in an independent cohort.
Main Results:
- 65 significantly differentially expressed miRNAs were identified (17 up-regulated, 48 down-regulated) in early-onset PE patients.
- Predicted target genes were enriched in pathways like Ras protein signal transduction, histone modification, TGF-β, PI3K-Akt, and MAPK signaling.
- Three miRNAs, including MIR7151, were validated, with MIR7151 showing significant differential expression and targeting KCNQ10T1.
Conclusions:
- Distinct miRNA expression profiles exist in peripheral blood exosomes between early-onset PE patients and healthy controls.
- These differentially expressed miRNAs are implicated in regulating key biological functions and signaling pathways relevant to PE pathophysiology.
- Candidate miRNAs, particularly MIR7151, show potential as biomarkers for early-onset PE.
Abstract:
Pre-eclampsia (PE), a major cause of perinatal morbidity and mortality, accounts for up to 14 % mortality of maternal and 18 % of fetal or infant mortalities. However, the pathogenesis process of PE remains unclear. The aim of this study was to identify differentially expressed microRNAs (miRNAs) in the peripheral blood exosomes of early-onset PE patients versus healthy pregnant women using high-throughput sequencing, and to find candidate miRNAs as molecular markers. Methods: Peripheral blood samples were collected from five preeclamptic patients and five healthy women. Exosomal miRNAs were sequenced using the Illumina HiSeq4000 sequencing platform. The target gene prediction, biological function enrichment, and signaling pathway prediction of the miRNAs with significant differences were carried out using the Starbase database software, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) databases, respectively. Our results showed 65 significantly differentially expressed miRNAs in the exosomes of early-onset PE patients compared to control group, with 17 up-regulated and 48 down-regulated (P < 0.05). A total of 2231 target genes were predicted for all differentially expressed miRNAs. Biological functions enriched by these target genes were mainly associated with Ras protein signal transduction, GTPase-mediated signal transduction regulation, histone modification, and β-transforming growth factor regulatory process. Key regulatory signaling pathways included TGF-β signaling pathway, PI3K-Akt signaling pathway, MAPK signaling pathway, tumor necrosis factor signaling pathway and EGFR tyrosine kinase inhibition signaling pathways. QPCR validation in 40 independent samples for 10 miRNAs, identified three miRNAs were confirmed in the second population. MIR7151 was a most significant differentially expressed miRNAs, and predicted its downstream regulatory gene, KCNQ10T1, using Starbase software. There were significant differences in miRNA expression profiles between peripheral blood exosomes of early-onset PE patients and normal pregnant women, suggesting that these miRNAs may contribute to the pathophysiology of early-onset PE by regulating various biological functions and signaling pathways.
More Related Videos
08:14MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019